Search

everythinglearnresearchcommunity

for

Search:↓

Tofacitinib improved hair regrowth and quality of life in children with alopecia areata, with mild side effects.

Timely treatments like PRP, topical, and drugs can effectively reduce hair loss.

COVID-19 can cause hair loss due to stress, with inflammation markers like D-dimer levels playing a role.

Transgender patients on masculinizing hormones have higher hair loss rates than cisgender women.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

Early hair loss common in Chinese males, linked to family history and smoking; early treatment advised.

The model accurately detects early-stage hair loss using images.

Dengue symptoms and liver issues can persist for over two months, especially in men.

Men taking dutasteride or finasteride have a slightly higher risk of developing type 2 diabetes.

Alopecia areata patients have varied cancer risks, with some cancers being lower and others higher.

One-third of COVID-19 patients had long-term symptoms like hair loss and fatigue, with women, older individuals, blood group B, smokers, and those with more virus exposure at higher risk.

Women with PCOS have lower zinc levels.

Alopecia areata greatly affects the quality of life for children and their families.

Repigmentation patterns in vitiligo depend on melanocyte source, lesion status, and therapy choice.

Most children with MIS-C showed significant improvement by 6 months.

Improving diet may help manage sleep disorders.

Adults with alopecia areata stick to their medication better than those with atopic dermatitis.

Taxane-based chemotherapy causes more hair loss and skin changes in Asian breast cancer patients.

Middle-aged women with PCOS often continue to experience symptoms related to high androgen levels, like unwanted hair growth.

5α-reductase inhibitors do not increase anaemia risk compared to α-blockers in men with BPH.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

The combination of spironolactone and low-dose minoxidil is generally safe for treating hair loss in adult females, with mostly mild side effects.

Finasteride and dutasteride have little effect on Type 2 Diabetes risk.

Virtual healthcare significantly improves quality of life for men with hair loss if they stick to the treatment.

Using 5-alpha reductase inhibitors may lower prostate cancer risk in people with androgenetic alopecia.

GLP-1RA therapy may increase the risk of hair loss.

High TNF-α levels may increase hair loss risk after PRP therapy.

Leucine levels may affect hair loss after bariatric surgery.

Minoxidil can temporarily increase hair shedding, causing anxiety and treatment discontinuation.